A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rivaroxaban Impurity 25 - Request Quote

Picture of Rivaroxaban Impurity 25

Rivaroxaban Impurity 25

SZ CAT No:SZ-R017052
CAS No
NA
Mol.F.
C28H31N5O8
Mol.Wt.
565.6
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Rivaroxaban Impurity 25 is chemically 4-(4-((((R)-2-oxo-3-(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)oxazolidin-5-yl)methyl)amino)phenyl)morpholin-3-one. Rivaroxaban Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Rivaroxaban Impurity 25

Purchase Rivaroxaban Impurity 25

Rivaroxaban Impurity 25 suppliers

Rivaroxaban Impurity 25 manufacturers

Rivaroxaban Impurity 25 price

Order Rivaroxaban Impurity 25

Enquire Rivaroxaban Impurity 25

Rivaroxaban Impurity 25 cost

Rivaroxaban Impurity 25 Supplier

Rivaroxaban Impurity 25 Distributor

Rivaroxaban Impurity 25 for Method Validation

Rivaroxaban Reference Standard

Rivaroxaban Impurity 25 for ANDA Filing

Rivaroxaban Impurity 25 for Forced Degradation Studies

Rivaroxaban Impurity 25 Identification Standards

Rivaroxaban Impurity 25 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,